Skip to main content

Cero Therapeutics Holdings, Inc.

CERO
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001870404

No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesCEROW

Q3 2022 vs. Q2 2022

How the institutions holding Cero Therapeutics Holdings, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CERO: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders5466+12
Shares14.4M15.2M+732.0K (+5.1%)
Value$144.5M$153.0M+$8.42M (+5.8%)

New holders (17)

Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CERO in Q3 2022
InstitutionSharesValue% of portfolio
Meteora Capital, LLC164,721$1.66M0.43%
Sea Otter Advisors LLC124,500$1.26M2.63%
JPMorgan Chase & Co100,000$1.01M0.00%
Shaolin Capital Management LLC99,328$1.00M0.03%
Mint Tower Capital Management B.V.80,000$807.0K0.07%
Basso Capital Management, L.P.74,926$756.0K0.18%
Captrust Financial Advisors53,484$540.0K0.00%
Parallax Volatility Advisers, L.P.33,721$340.0K0.01%
Landscape Capital Management, L.L.C.32,601$329.0K0.04%
Bank of Montreal31,866$322.0K0.00%
Virtu Financial LLC31,129$314.0K0.03%
Verition Fund Management LLC26,126$264.0K0.00%
Calamos Advisors LLC25,000$253.0K0.00%
Geode Capital Management, LLC10,588$106.0K0.00%
Old Mission Capital LLC10,456$106.0K0.00%
Glazer Capital, LLC10,221$103.0K0.00%
Elequin Capital LP1,600$16.0K0.01%

Sold out (5)

Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of CERO in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Cantor Fitzgerald, L. P.750,000$7.51M
Woodline Partners LP300,000$3.01M
CSS LLC276,745$2.77M
Picton Mahoney Asset Management150,000$1.50M
Crestline Management, LP25,000$251.0K